Business / Finance

RSS

Hill-Rom Holdings' fourth-quarter revenue increases 20% to $574 million

Hill-Rom Holdings, Inc. announced financial results for its fourth quarter ended September 30, 2015, and its fiscal year 2016 financial outlook. Adjusted earnings per diluted share of $0.89 increased 20 percent from $0.74 in the prior year.

5 Nov 2015

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Market leaders in temperature controlled microscopy, Linkam Scientific Instruments report on the use of their temperature controlled stages applied to CLEM and fluorescence microscopy to assist in endocytic sorting in the School of Biochemistry at the University of Bristol.

From Linkam Scientific Instruments 4 Nov 2015

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

Johnson & Johnson today announced a definitive agreement to acquire Novira Therapeutics, Inc., a privately held, clinical-stage biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection.

4 Nov 2015

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

BD (Becton, Dickinson and Company), a leading global medical technology company, today reported quarterly adjusted revenues of $3.067 billion for the fourth fiscal quarter ended September 30, 2015, an increase of 39.3 percent over the prior-year period as reported, or 49.1 percent on a currency-neutral basis.

4 Nov 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Allergan plc, a leading global pharmaceutical company, today announced that its wholly owned subsidiary has entered into an exclusive licensing agreement with Mimetogen Pharmaceuticals, a clinical stage biotechnology company, to develop and commercialize tavilermide (MIM-D3), a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease.

4 Nov 2015

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

Henry Schein, Inc., the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, today reported record third quarter financial results.

4 Nov 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

Mylan N.V. today announced the U.S. Federal Trade Commission has cleared the company's proposed transaction to acquire Perrigo Company plc subject to Mylan's divestiture of certain products following the consummation of the offer.

4 Nov 2015

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.5 million of securities in a registered direct offering.

4 Nov 2015

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

‘Stop the Pressure’ is the message from pressure ulcer specialist Rober, who is showcasing their wide range of innovative mattresses in support of Worldwide STOP Pressure Ulcer Day at MEDICA 2015, the world’s largest healthcare technology exhibition.

4 Nov 2015

Surgical startup seeks funding to build virtual reality training library

Medical Realities, a pioneering medical training startup, today announced that it is raising £400,000 in new investment to improve surgical education by creating a series of virtual and augmented reality training tutorials.

4 Nov 2015

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that following the American Medical Association’s (AMA) decision earlier this year to create a new Category I Current Procedural Terminology (CPT®) code for esophagogastric fundoplast...

3 Nov 2015

Denator forms a new Scientific Advisory Board

Denator AB has announced that a new external expert advisory board has been formed. Karsten Fjärstedt, recently appointed as CEO comments, “It is a great honor for me to be entrusted to lead Denator forward in this new phase of development. With a pipeline of new exciting business opportunities and a strong Scientific Advisory Board (SAB) I am looking forward to realizing the full potential of the company technology”.

3 Nov 2015

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).

3 Nov 2015

Digital health startup boot camp expands to US

Startupbootcamp, a global family of industry - focused accelerators, has today announced the launch of its first accelerator programs in North America, Startupbootcamp Digital Health.

3 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

Addus HomeCare’s net service revenues increase 3.3% to $84.3 million in Q3 2015

Addus HomeCare Corporation, a comprehensive provider of home and community-based services that are primarily personal in nature, provided in the home and focused on the dual eligible population, today announced its financial results for the third quarter and nine months ended September 30, 2015.

3 Nov 2015

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

HealthSouth Corporation, a leading provider of post-acute healthcare services, today announced its Encompass Home Health business unit has completed its previously announced acquisition of the home health and hospice agency operations of CareSouth Health System, Inc.

2 Nov 2015

Xcelience announces grand opening of new headquarters in Tampa

Xcelience is proud to announce the grand opening of its new 71,000 square foot headquarters located at 4910 Savarese Circle in Tampa. The building houses preformulation and formulation development labs and suites, as well as analytical and stability services. The official ribbon cutting ceremony was attended by Florida Governor Rick Scott, Tampa Mayor Bob Buckhorn and other elected and non-elected officials.

31 Oct 2015

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Alexza Pharmaceuticals, Inc. announced today that it plans to reacquire the U.S. rights for ADASUVE (loxapine) inhalation powder from Teva Pharmaceuticals USA, Inc., a subsidiary of Teva Pharmaceutical Industries Ltd., with an estimated target completion date of January 1, 2016.

31 Oct 2015

Q BioMed signs definitive license agreement with Mannin Research

Q BioMed Inc., a biotechnology acceleration company is pleased to announce it has signed a definitive license, with the option to acquire, the platform technology assets of Mannin Research Inc.

30 Oct 2015

Business / Finance

Hill-Rom Holdings' fourth-quarter revenue increases 20% to $574 million

Linkam stages in use in the Wolfson Bioimaging Facility at the University of Bristol as part of the endocytic sorting research of Dr Paul Verkade

Johnson & Johnson signs definitive agreement to purchase Novira Therapeutics

BD reports quarterly adjusted revenues of $3.067 billion for fourth fiscal quarter 2015

Allergan signs licensing agreement with Mimetogen to develop, commercialize tavilermide for treatment of dry eye disease

Henry Schein's net sales increase 2.4% to $2.7 billion in third quarter 2015

U.S. FTC clears Mylan's proposed transaction to acquire Perrigo

OncoSec signs definitive agreements to purchase $7.5 million of securities in registered direct offering

‘Zero pressure’ mattress solutions to be showcased at MEDICA 2015

Surgical startup seeks funding to build virtual reality training library

Medigus announces CMS’ publication of fee schedules for endoscopic fundoplication procedures under CPT code 43210 effective January 2016

Denator forms a new Scientific Advisory Board

Alnylam presents positive ongoing phase 2 open-label extension data for Patisiran and Revusiran

Digital health startup boot camp expands to US

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

Addus HomeCare’s net service revenues increase 3.3% to $84.3 million in Q3 2015

HealthSouth acquires home health and hospice agency operations of CareSouth Health System

Xcelience announces grand opening of new headquarters in Tampa

Alexza plans to reacquire U.S. rights for ADASUVE (loxapine) inhalation powder from Teva

Q BioMed signs definitive license agreement with Mannin Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News